Glanzmann thrombasthenia 1
MONDO:0031332A bleeding syndrome characterized by spontaneous mucocutaneous bleeding and an exaggerated response to trauma due to a constitutional thrombocytopenia
Also known as: Glanzmann thrombasthenia, Glanzmann's thrombasthenia, BDPLT2, Glanzmann thrombasthenia 1, platelet glycoprotein IIb-IIIa deficiency, thrombasthenia, thrombasthenia of Glanzmann and Naegeli, Diacyclothrombopathia 2B 3A
18 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New antibody aims to stop bleeding episodes in rare clotting disorder
Disease control OngoingThis early-phase trial tests an experimental antibody called HMB-001 in 57 adults with Glanzmann thrombasthenia, a rare bleeding disorder. The study aims to see if the drug is safe and can reduce the number and severity of bleeds when given regularly. Participants receive single …
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
AI takes on blood clotting: can ChatGPT guide surgeons on bleeding?
Knowledge-focused TerminatedThis study evaluates whether artificial intelligence models can accurately interpret ROTEM blood clotting tests and recommend treatments for coagulopathy. Researchers will compare AI decisions to those of a panel of clinical experts using data from adults undergoing elective card…
Sponsor: Ondokuz Mayıs University • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC